Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Metabolic Phenotypes of Response to Vaccination in Humans.

Li S, Sullivan NL, Rouphael N, Yu T, Banton S, Maddur MS, McCausland M, Chiu C, Canniff J, Dubey S, Liu K, Tran V, Hagan T, Duraisingham S, Wieland A, Mehta AK, Whitaker JA, Subramaniam S, Jones DP, Sette A, Vora K, Weinberg A, Mulligan MJ, Nakaya HI, Levin M, Ahmed R, Pulendran B.

Cell. 2017 May 18;169(5):862-877.e17. doi: 10.1016/j.cell.2017.04.026. Epub 2017 May 11.

2.

Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.

Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, Frasca D, Gersten M, Mehta AK, Gaujoux R, Li GM, Gupta S, Ahmed R, Mulligan MJ, Shen-Orr S, Blomberg BB, Subramaniam S, Pulendran B.

Immunity. 2015 Dec 15;43(6):1186-98. doi: 10.1016/j.immuni.2015.11.012.

3.

Human blood CD1c dendritic cells stimulate IL-12-independent IFN-γ responses and have a strikingly low inflammatory profile.

Benlahrech A, Duraisingham S, King D, Verhagen L, Rozis G, Amjadi P, Ford T, Kelleher P, Patterson S.

J Leukoc Biol. 2015 May;97(5):873-885. doi: 10.1189/jlb.1A0114-058RR. Epub 2015 Mar 12.

PMID:
25765676
4.

Immune deficiency: changing spectrum of pathogens.

Duraisingham SS, Manson A, Grigoriadou S, Buckland M, Tong CY, Longhurst HJ.

Clin Exp Immunol. 2015 Aug;181(2):267-74. doi: 10.1111/cei.12600.

5.

Pseudomonas infection in antibody deficient patients.

Duraisingham SS, Hanson S, Buckland M, Grigoriadou S, Longhurst HJ.

Eur J Microbiol Immunol (Bp). 2014 Dec;4(4):198-203. doi: 10.1556/EUJMI-D-14-00026. Epub 2014 Dec 16.

6.

Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.

Duraisingham SS, Buckland M, Dempster J, Lorenzo L, Grigoriadou S, Longhurst HJ.

PLoS One. 2014 Jun 27;9(6):e100324. doi: 10.1371/journal.pone.0100324. eCollection 2014.

7.

Secondary antibody deficiency.

Duraisingham SS, Buckland MS, Grigoriadou S, Longhurst HJ.

Expert Rev Clin Immunol. 2014 May;10(5):583-91. doi: 10.1586/1744666X.2014.902314. Epub 2014 Mar 31.

PMID:
24684706
8.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2014 Feb;15(2):195-204. doi: 10.1038/ni.2789. Epub 2013 Dec 15.

9.

Predicting network activity from high throughput metabolomics.

Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA, Jones DP, Pulendran B.

PLoS Comput Biol. 2013;9(7):e1003123. doi: 10.1371/journal.pcbi.1003123. Epub 2013 Jul 4.

10.

Systems biology of vaccination in the elderly.

Duraisingham SS, Rouphael N, Cavanagh MM, Nakaya HI, Goronzy JJ, Pulendran B.

Curr Top Microbiol Immunol. 2013;363:117-42. doi: 10.1007/82_2012_250. Review.

PMID:
22903566
11.

CD34-derived human Langerhans cells stimulate a T helper type 2 response independently of extracellular-signal-regulated kinase phosphorylation.

Duraisingham SS, Hornig J, Gotch F, Patterson S.

Immunology. 2010 Oct;131(2):210-9. doi: 10.1111/j.1365-2567.2010.03295.x.

12.

TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.

Duraisingham SS, Hornig J, Gotch F, Patterson S.

J Immunol. 2009 Aug 15;183(4):2242-51. doi: 10.4049/jimmunol.0900474. Epub 2009 Jul 22.

13.

Human Langerhans' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands.

Rozis G, Benlahrech A, Duraisingham S, Gotch F, Patterson S.

Immunology. 2008 Jul;124(3):329-38. doi: 10.1111/j.1365-2567.2007.02770.x. Epub 2008 Jan 11.

14.

ASPP1 and ASPP2: common activators of p53 family members.

Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X.

Mol Cell Biol. 2004 Feb;24(3):1341-50.

Supplemental Content

Loading ...
Support Center